Clean Science invests ₹50 crore in subsidiary Clean Fino-Chem
- Clean Science & Technology invested ₹50 crore in Clean Fino-Chem
- Subscription price included a premium of ₹588 per share
- Subsidiary turnover rose from ₹1.92 crore in FY24 to ₹166 crore in FY26
- Funds will be used for funding speciality chemical projects

*this image is generated using AI for illustrative purposes only.
Clean Science & Technology subscribed to the rights issue of its wholly owned subsidiary, Clean Fino-Chem Limited, for ₹50 crore. The investment aims to fund ongoing projects at the speciality chemicals unit.
The company acquired 8,36,121 equity shares at a face value of ₹10 each with a premium of ₹588 per share. This transaction constitutes 100% subscription to the additional equity share capital in cash. The new shares rank pari passu with existing equity shares.
Subsidiary Performance and Capital Deployment
Clean Fino-Chem was incorporated on March 22, 2022, to manufacture and sell speciality chemicals. The subsidiary has shown rapid revenue expansion since inception. The additional capital is primarily designated for funding its projects.
| Financial Year | Turnover (₹ crore) |
|---|---|
| FY26 | 166.0 |
| FY25 | 46.77 |
| FY24 | 1.92 |
Regulatory Disclosures
The transaction falls under related party transactions as Clean Fino-Chem is a wholly owned subsidiary. The company stated that the transaction is conducted at arm's length. No other promoter group entities hold an interest in this specific acquisition. The event occurred on September 23, 2026, at 12:30 pm.
Historical Stock Returns for Clean Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.41% | +1.99% | +1.34% | +19.75% | -26.81% | -60.59% |
How will the ₹50 crore capital infusion specifically accelerate the commissioning timeline of Clean Fino-Chem's speciality chemicals projects?
What is the projected impact on Clean Science & Technology's consolidated debt levels given the cash-based nature of this subsidiary investment?
Can Clean Fino-Chem sustain its exponential revenue growth trajectory beyond FY26 without further dilutive external funding?


































